Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Annual Results 2017 LONDON, 23 April 2018: Arix Bioscience plc (LSE:ARIX) ("Arix Bioscience", "Arix" or the "Company"), a global life sciences company supporting medical innovation, today...
-
CEO Letter to Shareholders LONDON, 4 January 2018: As 2018 gets underway, I would like to reflect on Arix Bioscience plc's (LSE: ARIX) ("Arix Bioscience" or "Arix") first year as a public...
-
Arix Bioscience co-leads $30 million financing for Aura Biosciences Funding to advance development of Aura's novel treatment to selectively destroy cancer cells; lead candidate AU-011 currently...
-
Arix Bioscience leads $30 million financing for Atox Bio Funding to advance Reltecimod into a Phase 2 clinical study for acute kidney injury, building upon Atox Bio's on-going Phase 3 clinical...
-
Arix Bioscience notes Harpoon Therapeutics' immuno-oncology collaboration with AbbVie LONDON, 18 October 2017: Arix Bioscience plc (LSE: ARIX) ("Arix Bioscience"), a global healthcare and life...
-
Arix Bioscience appoints Giles Kerr to Board of Directors LONDON, 17 October 2017: Arix Bioscience plc (LSE: ARIX) ("Arix Bioscience" or "the Company"), a global healthcare and life science...
-
Arix Bioscience notes positive Phase I clinical and non-clinical data from Amplyx for the treatment of life-threatening fungal infections LONDON, 10 October 2017: Arix Bioscience plc (LSE: ARIX)...
-
Arix Bioscience participates in $80 million Series C financing for Autolus LONDON, 26 September 2017: Arix Bioscience plc (LSE: ARIX) ("Arix Bioscience" or "Arix"), a global healthcare and life...
-
Arix Bioscience plc notes positive clinical study announcements from Autolus Limited LONDON, 18 September 2017: Arix Bioscience plc (LSE: ARIX) ("Arix Bioscience"), a global healthcare and life...
-
Arix Bioscience plc notes positive trial data from Verona Pharma in COPD LONDON, 7 September 2017: Arix Bioscience plc (LSE: ARIX) ("Arix Bioscience"), a global healthcare and life science...